September 2, 2014 — In an agreement signed in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corp. (TMSC) wider distribution rights regarding linear accelerator (linac) sales. The agreement builds on a sales and marketing agreement from 2010.

Shuichi Higaki, president and managing director, Elekta Japan, said: “The existing partnership between Elekta and TMSC from 2010 has helped raise Elekta’s profile in the Japanese market. This new agreement creates significant opportunities for Elekta to further increase our customer satisfaction and become the leading supplier of oncology systems and related software solutions in Japan.”

Since Siemens’s departure from the linac market in 2011, TMSC still has an installed base of about 200 aging Siemens linear accelerators. The extended partnership opens up additional sales channels for Elekta’s linacs and software products and gives Elekta the opportunity to convert existing Siemens Lantis oncology information systems (OIS) that were sold through TMSC.

The agreement also includes the intention to develop the Elekta Support Center, a centralized customer support center with a single point of contact for all Elekta linac users in Japan. Elekta will continue to manage marketing and promotion of all Elekta products and solutions, as well as education and training and software service support.

For more information: www.elekta.com


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now